These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14511308)

  • 21. Acquired factor VIII inhibitors in nonhemophilic patients.
    Söhngen D; Specker C; Bach D; Kuntz BM; Burk M; Aul C; Kobbe G; Heyll A; Hollmig KA; Schneider W
    Ann Hematol; 1997 Feb; 74(2):89-93. PubMed ID: 9063379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro reactivity of factor VIII inhibitors with von Willebrand factor in different commercial factor VIII concentrates.
    Tagariello G; Zanotto D; Radossi P; Sartori R; Belvini D; Salviato R
    Am J Hematol; 2007 Jun; 82(6):460-2. PubMed ID: 17211843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor.
    Masuhara K; Shimizu T; Kawasaki N; Fukui H; Sakai Y; Shima M; Mikami S; Yoshioka A
    Nihon Seikeigeka Gakkai Zasshi; 1982 Dec; 56(12):1719-27. PubMed ID: 6820658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Factor VIII inhibitors in patients suffering from severe haemophilia A: problems of "very low" responders].
    Lutze G; Aumann V; Lutze G; Mittler U
    Klin Padiatr; 2001; 213(6):321-4. PubMed ID: 11713709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of inhibitors in persons with non-severe hemophilia A in the United States.
    Lim MY; Cheng D; Recht M; Kempton CL; Key NS
    Am J Hematol; 2021 Jan; 96(1):E9-E11. PubMed ID: 32976635
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisolone.
    Holstein K; Marx G; Lentz B; Bokemeyer C; Langer F
    Hamostaseologie; 2012; 32 Suppl 1():S48-51. PubMed ID: 22960877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of non-activated prothrombin complex concentrate (Proplex ST) on intraperitoneal hematoma in a hemophilia A patient with a factor VIII inhibitor.
    Kagawa H; Yasuzawa M; Ozaki Y; Yamamoto Y; Katsurada T; Nomura S; Okubo S; Fukuhara S
    Intern Med; 1996 Apr; 35(4):319-22. PubMed ID: 8739790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors.
    Chuansumrit A; Sirachainan N; Panuwannakorn M; Wongwerawattanakoon P; Kadegasem P; Choeyprasert W; Sasanakul W
    Haemophilia; 2013 May; 19(3):e182-3. PubMed ID: 23600908
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of acquired hemophilia with oral immunosuppressive therapy.
    Shaffer LG; Phillips MD
    Ann Intern Med; 1997 Aug; 127(3):206-9. PubMed ID: 9245226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW; Saidi P; Philipp C
    Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIII inhibitor postpartum.
    Michiels JJ; Bosch LJ; van der Plas PM; Abels J
    Scand J Haematol; 1978 Feb; 20(2):97-107. PubMed ID: 305611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Development of Factor VIII Inhibitor in a Patient with an Uncommon de novo Mutation in the Factor VIII Gene.
    Wyatt KD; Coon LM; Rusk DN; Rodriguez V; Warad DM
    Acta Haematol; 2019; 141(3):129-134. PubMed ID: 30783064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The problem of factor VIII inhibitors in patients with congenital coagulopathies].
    Klare M
    Z Gesamte Inn Med; 1983 Jan; 38(2):47-50. PubMed ID: 6407220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
    Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporarily successful eradication therapy in acquired haemophilia with high inhibitor titer: a case report with a new protocol.
    Ilonczai P; Schlammadinger A; Oláh Z; Rázsó K; Bereczky Z; Boda Z
    Thromb Haemost; 2008 Jul; 100(1):149-50. PubMed ID: 18612550
    [No Abstract]   [Full Text] [Related]  

  • 40. Orthotopic liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor from an antithrombin-deficient cadaveric donor.
    Gregg R; Lester W; Bramhall S; Wilde J
    Haemophilia; 2013 Mar; 19(2):e96-7. PubMed ID: 23419109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.